| Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation R Afrin, S Arumugam, A Rahman, MII Wahed, V Karuppagounder, ... International immunopharmacology 44, 174-182, 2017 | 124 | 2017 |
| Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis V Karuppagounder, S Arumugam, RA Thandavarayan, R Sreedhar, ... Drug discovery today 21 (4), 632-639, 2016 | 113 | 2016 |
| Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems T Madheswaran, M Kandasamy, RJC Bose, V Karuppagounder Drug discovery today 24 (7), 1405-1412, 2019 | 96 | 2019 |
| Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice V Karuppagounder, S Arumugam, RA Thandavarayan, V Pitchaimani, ... Experimental dermatology 24 (6), 418-423, 2015 | 95 | 2015 |
| Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats R Afrin, S Arumugam, V Soetikno, RA Thandavarayan, V Pitchaimani, ... Free Radical Research 49 (3), 279-289, 2015 | 83 | 2015 |
| Lipid–polymer hybrid nanoparticle- mediated therapeutics delivery: advances and challenges TRA Bose RJC, Ravikumar R, Karuppagounder V, Bennet D, Rangasamy S Drug Discov Today 22 (8), 1258-1265, 2017 | 81 | 2017 |
| Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice V Karuppagounder, S Arumugam, RA Thandavarayan, V Pitchaimani, ... International Immunopharmacology 23 (2), 617-623, 2014 | 81 | 2014 |
| Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease R Sreedhar, S Arumugam, RA Thandavarayan, V Karuppagounder, ... Drug discovery today 21 (5), 843-849, 2016 | 72 | 2016 |
| Modulation of macrophage polarization and HMGB1-TLR2/TLR4 cascade plays a crucial role for cardiac remodeling in senescence-accelerated prone mice V Karuppagounder, VV Giridharan, S Arumugam, R Sreedhar, ... PloS one 11 (4), e0152922, 2016 | 70 | 2016 |
| Angiotensin receptor blockers: Focus on cardiac and renal injury S Arumugam, R Sreedhar, RA Thandavarayan, V Karuppagounder, ... Trends in cardiovascular medicine 26 (3), 221-228, 2016 | 64 | 2016 |
| Tannic acid modulates NFκB signaling pathway and skin inflammation in NC/Nga mice through PPARγ expression V Karuppagounder, S Arumugam, RA Thandavarayan, V Pitchaimani, ... Cytokine 76 (2), 206-213, 2015 | 63 | 2015 |
| Tiny molecule, big power: multi-target approach for curcumin in diabetic cardiomyopathy V Karuppagounder, S Arumugam, VV Giridharan, R Sreedhar, RJC Bose, ... Nutrition 34, 47-54, 2017 | 54 | 2017 |
| Curcumin alleviates renal dysfunction and suppresses inflammation by shifting from M1 to M2 macrophage polarization in daunorubicin induced nephrotoxicity in rats V Karuppagounder, S Arumugam, RA Thandavarayan, R Sreedhar, ... Cytokine 84, 1-9, 2016 | 52 | 2016 |
| Aspiration-assisted bioprinting of the osteochondral interface B Ayan, Y Wu, V Karuppagounder, F Kamal, IT Ozbolat Scientific reports 10 (1), 13148, 2020 | 47 | 2020 |
| Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation V Karuppagounder, S Arumugam, RA Thandavarayan, V Pitchaimani, ... International immunopharmacology 28 (1), 154-159, 2015 | 47 | 2015 |
| The senescence accelerated mouse prone 8 (SAMP8): a novel murine model for cardiac aging V Karuppagounder, S Arumugam, SS Babu, SS Palaniyandi, K Watanabe, ... Ageing research reviews 35, 291-296, 2017 | 45 | 2017 |
| Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats KW Vengadeshprabhu Karuppa Gounder, Somasundaram Arumugama, Wawaimuli Arozal ... International immunopharmacology 18 (22), 282–289, 2013 | 40* | 2013 |
| Role of MAPK‐mediated endoplasmic reticulum stress signaling in the heart during aging in senescence‐accelerated prone mice R Sreedhar, VV Giridharan, S Arumugam, V Karuppagounder, ... Biofactors 42 (4), 368-375, 2016 | 39 | 2016 |
| Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis EL Carlson, V Karuppagounder, WJ Pinamont, NK Yoshioka, A Ahmad, ... Science Translational Medicine 13 (580), eaau8491, 2021 | 34 | 2021 |
| Naringenin ameliorates skin inflammation and accelerates phenotypic reprogramming from M1 to M2 macrophage polarization in atopic dermatitis NC/Nga mouse model V Karuppagounder, S Arumugam, RA Thandavarayan, R Sreedhar, ... Experimental dermatology 25 (5), 404-407, 2016 | 33 | 2016 |
Somasundaram ArumugamNational Institute of Pharmaceutical Education and Research, KolkataVerified email at niperkolkata.edu.in
